http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-577119-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_170f3f512b711fe819f7292197d4384b |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-40 |
| filingDate | 2010-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_768defcf933aa5fa286747530609ec63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae95d6b70e158b49db5eb9a86611ae1c |
| publicationDate | 2012-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NZ-577119-A |
| titleOfInvention | Treatment of microbial infections such as mastitis with a peroxide generating system |
| abstract | Disclosed is a method of treating or preventing mastitis in a non-human animal, said method comprises the step of applying a medicament to the mammary gland of the non-human animal; wherein the medicament contains an extended acting oxygen generating system which has at least two components: (i) one component being a slow release hydrogen peroxide generation system, and; (ii) another component being an activator in the form of a halide or thiocyanate substrate; wherein the extended acting oxygen generating system is configured to provide oxygen generation over a time period between 30 seconds to 14 hours following administration to an animal, and the two or more components present in the medicament are in a form prior to administration to an animal that prevents oxygen generation until during or after administration and controlled thereafter. |
| priorityDate | 2010-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 136.